• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

致幻剂:最新进展

Hallucinogens: an update.

作者信息

Halpern John H

机构信息

Biological Psychiatry Laboratory, Alcohol and Drug Abuse Research Center, McLean Hospital, 115 Mill Street, Belmont, MA 02478, USA.

出版信息

Curr Psychiatry Rep. 2003 Oct;5(5):347-54. doi: 10.1007/s11920-003-0067-4.

DOI:10.1007/s11920-003-0067-4
PMID:13678554
Abstract

Research of hallucinogen abuse rarely extends beyond epidemiology and observed pathology. Even less research has been completed on the special circumstances surrounding the religious use of hallucinogens or on potential therapeutic applications. Rather than offer another basic review on the well-known hazards of illicit hallucinogen use, this paper provides an overview and practice recommendations on compounds the clinician may be less familiar with, such as the botanical plant Salvia divinorum, the drug 3,4-methylenedioxymethamphetamine ("ecstasy") and synthetic hallucinogen analogs. The often-warned, but rarely occurring, hazard of hallucinogen persisting perception disorder ("flashbacks") is also reviewed with treatment recommendations provided. The current status of clinical research with the hallucinogens is presented, with case vignettes suggesting hallucinogens may have anti-addictive applications. The special circumstances surrounding the religious, nondrug use of hallucinogens as sacred sacraments in the US and elsewhere are also presented. It is hoped that the reader will gain a more nuanced understanding of how these physiologically nonaddictive drugs may offer legitimate benefits in modern society. By appreciating that such benefits may one day be borne out by careful, methodologically sound research, clinicians should be better armed in raising the topic of hallucinogen use and abuse with their patients.

摘要

对致幻剂滥用的研究很少超出流行病学和观察到的病理学范畴。对于围绕致幻剂宗教用途的特殊情况或潜在治疗应用的研究则更少。本文并非对非法使用致幻剂的已知危害进行又一次基础综述,而是对临床医生可能不太熟悉的化合物提供概述和实践建议,比如植物鼠尾草、药物3,4 - 亚甲基二氧甲基苯丙胺(“摇头丸”)以及合成致幻剂类似物。还对常被警告但很少发生的致幻剂持续性感知障碍(“闪回”)危害进行了综述并给出治疗建议。介绍了致幻剂临床研究的现状,通过病例 vignettes表明致幻剂可能具有抗成瘾应用。还介绍了在美国和其他地方将致幻剂作为神圣圣礼进行宗教性、非药物使用的特殊情况。希望读者能对这些生理上无成瘾性的药物如何在现代社会提供合理益处有更细致入微的理解。通过认识到这种益处可能有朝一日会被严谨、方法得当的研究所证实,临床医生在与患者讨论致幻剂使用及滥用话题时应能更有底气。

相似文献

1
Hallucinogens: an update.致幻剂:最新进展
Curr Psychiatry Rep. 2003 Oct;5(5):347-54. doi: 10.1007/s11920-003-0067-4.
2
Hallucinogen persisting perception disorder: what do we know after 50 years?致幻剂持续性感知障碍:50年后我们了解了什么?
Drug Alcohol Depend. 2003 Mar 1;69(2):109-19. doi: 10.1016/s0376-8716(02)00306-x.
3
[Synesthesias in the context of hallucinogen-induced persistent perception disorder following the use of lsd].[使用麦角酸二乙胺(LSD)后致幻剂所致持续性感知障碍背景下的联觉]
Tijdschr Psychiatr. 2014;56(11):748-52.
4
Who takes the trip? Personality and hallucinogen use among college students and adolescents.谁会有这样的经历?人格特质与大学生和青少年使用迷幻剂。
Drug Alcohol Depend. 2020 Dec 1;217:108263. doi: 10.1016/j.drugalcdep.2020.108263. Epub 2020 Aug 30.
5
Schizophrenia and hallucinogen persisting perception disorder: A clinical investigation.精神分裂症与致幻剂持续性感知障碍:一项临床研究。
Am J Addict. 2015 Apr;24(3):197-199. doi: 10.1111/ajad.12204. Epub 2015 Mar 24.
6
Hallucinogen persisting perception disorder after psilocybin consumption: a case study.食用裸盖菇素后出现的致幻剂持续性感知障碍:一项病例研究。
Eur Psychiatry. 2005 Aug;20(5-6):458-60. doi: 10.1016/j.eurpsy.2005.04.008.
7
Hallucinogen Persisting Perception Disorder and Risk of Suicide.致幻剂持续性感知障碍与自杀风险
J Pharm Pract. 2016 Aug;29(4):431-4. doi: 10.1177/0897190014566314. Epub 2015 Jan 27.
8
A regulatory perspective on the evaluation of hallucinogen drugs for human use.从监管角度评估致幻剂类药物在人类中的使用。
Neuropharmacology. 2018 Nov;142:135-142. doi: 10.1016/j.neuropharm.2017.11.028. Epub 2017 Nov 24.
9
Clonidine treatment for hallucinogen persisting perception disorder.可乐定治疗致幻剂持续性感知障碍。
Am J Psychiatry. 1998 Oct;155(10):1460. doi: 10.1176/ajp.155.10.1460.
10
Salvia divinorum: An overview of the usage, misuse, and addiction processes.鼠尾草:使用、滥用及成瘾过程概述。
Asia Pac Psychiatry. 2016 Mar;8(1):23-31. doi: 10.1111/appy.12225. Epub 2015 Nov 29.

引用本文的文献

1
Developmental trajectories of illicit drug use, prescription drug misuse and cannabis practices among young adult cannabis users in Los Angeles.洛杉矶年轻成年大麻使用者中非法药物使用、处方药物滥用和大麻使用的发展轨迹。
Drug Alcohol Rev. 2020 Sep;39(6):743-752. doi: 10.1111/dar.13078. Epub 2020 May 10.
2
Population Survey Data Informing the Therapeutic Potential of Classic and Novel Phenethylamine, Tryptamine, and Lysergamide Psychedelics.人口调查数据揭示经典和新型苯乙胺、色胺及麦角酰胺类致幻剂的治疗潜力
Front Psychiatry. 2020 Feb 11;10:896. doi: 10.3389/fpsyt.2019.00896. eCollection 2019.
3
Embedding existential psychology within psychedelic science: reduced death anxiety as a mediator of the therapeutic effects of psychedelics.

本文引用的文献

1
A clinical plan for MDMA (Ecstasy) in the treatment of posttraumatic stress disorder (PTSD): partnering with the FDA.一项关于摇头丸(迷幻药)治疗创伤后应激障碍(PTSD)的临床计划:与美国食品药品监督管理局合作。
J Psychoactive Drugs. 2002 Apr-Jun;34(2):185-94. doi: 10.1080/02791072.2002.10399952.
2
Altered states: the clinical effects of Ecstasy.改变的状态:摇头丸的临床效果。
Pharmacol Ther. 2003 Apr;98(1):35-58. doi: 10.1016/s0163-7258(03)00003-2.
3
Mood, cognition and serotonin transporter availability in current and former ecstasy (MDMA) users.
将存在主义心理学嵌入迷幻科学中:降低死亡焦虑作为迷幻药物治疗效果的中介。
Psychopharmacology (Berl). 2020 Jan;237(1):21-32. doi: 10.1007/s00213-019-05391-0. Epub 2019 Nov 29.
4
Hallucinogen-persisting perception disorder.幻觉持续感知障碍。
Ther Adv Psychopharmacol. 2012 Oct;2(5):199-205. doi: 10.1177/2045125312451270.
5
Culture, psychosomatics and substance abuse: the example of body image drugs.文化、身心医学与药物滥用:以身体意象药物为例。
Psychother Psychosom. 2012;81(2):73-8. doi: 10.1159/000330415. Epub 2012 Jan 18.
6
The psychotherapeutic potential of MDMA (3,4-methylenedioxymethamphetamine): an evidence-based review.摇头丸(3,4-亚甲基二氧甲基苯丙胺)的心理治疗潜力:一项基于证据的综述。
Psychopharmacology (Berl). 2007 Apr;191(2):181-93. doi: 10.1007/s00213-007-0703-5. Epub 2007 Feb 13.
当前及既往摇头丸(MDMA)使用者的情绪、认知与血清素转运体可用性
Psychopharmacology (Berl). 2003 Apr;167(1):85-96. doi: 10.1007/s00213-002-1383-9. Epub 2003 Mar 11.
4
Hallucinogen persisting perception disorder: what do we know after 50 years?致幻剂持续性感知障碍:50年后我们了解了什么?
Drug Alcohol Depend. 2003 Mar 1;69(2):109-19. doi: 10.1016/s0376-8716(02)00306-x.
5
A review of 19 double-blind placebo-controlled studies in social anxiety disorder (social phobia).一项针对社交焦虑障碍(社交恐惧症)的19项双盲安慰剂对照研究的综述。
World J Biol Psychiatry. 2000 Jan;1(1):27-33. doi: 10.3109/15622970009150563.
6
Ketamine psychotherapy for heroin addiction: immediate effects and two-year follow-up.氯胺酮心理疗法治疗海洛因成瘾:即时效果及两年随访
J Subst Abuse Treat. 2002 Dec;23(4):273-83. doi: 10.1016/s0740-5472(02)00275-1.
7
Addiction treatment strives for legitimacy.成瘾治疗力求合法化。
JAMA. 2002 Dec 25;288(24):3096, 3099-101. doi: 10.1001/jama.288.24.3096.
8
Psychiatric disorders in Ecstasy (MDMA) users: a literature review focusing on personal predisposition and drug history.
Hum Psychopharmacol. 2001 Dec;16(8):641-645. doi: 10.1002/hup.350.
9
Salvinorin A: a potent naturally occurring nonnitrogenous kappa opioid selective agonist.Salvinorin A:一种强效的天然非含氮κ阿片受体选择性激动剂。
Proc Natl Acad Sci U S A. 2002 Sep 3;99(18):11934-9. doi: 10.1073/pnas.182234399. Epub 2002 Aug 21.
10
The 'sextasy' craze. Clubland's dangerous party mix: Viagra and ecstasy.
Newsweek. 2002 Jun 3;139(22):30.